RP Bio Inc. (KOSDAQ:314140)

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61,964	43,765	74,964	102,515	-	-
Market Cap Growth	13.31%	-41.62%	-26.88%	-	-	-
Enterprise Value	67,782	58,375	92,754	118,331	-	-
Last Close Price	7150.00	5050.00	8650.00	12474.49	-	-
PE Ratio	20.36	-	13.79	23.75	-	-
PS Ratio	0.48	0.35	0.50	0.74	-	-
PB Ratio	0.59	0.43	0.73	1.13	-	-
P/TBV Ratio	0.59	0.43	0.73	1.13	-	-
P/FCF Ratio	8.54	5.71	-	-	-	-
P/OCF Ratio	4.87	3.24	7.09	88.76	-	-
EV/Sales Ratio	0.53	0.47	0.61	0.86	-	-
EV/EBITDA Ratio	6.80	9.53	7.32	7.86	-	-
EV/EBIT Ratio	21.09	-	14.01	12.27	-	-
EV/FCF Ratio	9.35	7.61	-	-	-	-
Debt / Equity Ratio	0.20	0.30	0.30	0.42	0.59	0.63
Debt / EBITDA Ratio	2.09	4.93	2.43	2.54	3.64	4.68
Debt / FCF Ratio	2.88	3.94	-	-	18.23	-
Asset Turnover	0.81	0.76	0.89	0.87	0.84	0.78
Inventory Turnover	4.39	4.02	3.73	3.94	5.24	5.85
Quick Ratio	0.71	0.71	0.57	0.50	0.41	0.40
Current Ratio	1.34	1.19	1.18	1.03	0.73	0.66
Return on Equity (ROE)	2.93%	-0.89%	5.61%	5.39%	5.73%	7.68%
Return on Assets (ROA)	1.26%	-0.27%	2.44%	3.81%	2.68%	2.07%
Return on Capital (ROIC)	1.55%	-0.33%	3.15%	5.05%	3.44%	2.63%
Return on Capital Employed (ROCE)	2.80%	-	6.10%	10.20%	8.10%	6.40%
Earnings Yield	4.90%	-2.07%	7.25%	4.21%	-	-
FCF Yield	11.70%	17.53%	-0.73%	-3.89%	-	-
Buyback Yield / Dilution	7.66%	7.41%	-31.19%	-8.34%	1.16%	-1.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.